For the first time ever, new data from the American Cancer Society (ACS) shows that 7 in 10 people diagnosed with cancer in the U.S. now survive at least five years. According to Cancer Statistics, 2026, this milestone reflects decades of research, innovation, and improvements in how cancer is diagnosed and treated. Below are some of the key takeaways from the new data.

A turning point in cancer survival

The ACS reports that the overall five-year relative survival rate for all cancers combined reached 70% for people diagnosed between 2015 and 2021, up from about 50% in the mid-1970s. Survival gains have been especially striking for cancers that were once considered among the most fatal:

• Multiple myeloma: survival increased from 32% to 62%
• Liver cancer: survival rose from 7% to 22%
• Lung cancer: survival nearly doubled from 15% to 28%

These improvements reflect advances in targeted therapies, immunotherapy, better imaging, earlier detection, and a deeper understanding of cancer biology, all of which are changing what it means to live with cancer.

Access to the latest treatments matters

While survival is improving overall, the ACS report also highlights ongoing challenges. In 2026, more than 2.1 million people are expected to be diagnosed with cancer.

Progress in cancer care is not reaching everyone equally. Socioeconomic factors, including insurance status, income, and access to high-quality cancer centers, can limit who benefits from new treatments and early diagnosis. As a result, certain populations continue to experience higher cancer mortality, underscoring the need for more equitable access to care.

Ensuring equitable care, insurance coverage, clinical trial access, and supportive resources is key to moving cancer care forward for everyone.

Living longer means supporting survivorship

Survivorship has become a central part of cancer care. This stage of care goes beyond treating the disease and includes managing:

• Long-term side effects
• Emotional and mental health challenges
• Changes in relationships
• Financial stress and caregiving needs

More survivors means a greater need for coordinated support, education, and resources that help people not just live longer, but live better.

The importance of personalized treatment options

No cancer is the same. Even two people with the same cancer type may have very different treatment options. Precision medicine is transforming cancer care by matching treatments to the unique features of each person’s cancer, such as genetic changes, biomarkers, and how the disease behaves in the body. Progress in personalized approaches is improving both survival and quality of life for patients.

What this means for you

Cancer survival is improving and staying informed remains essential. Understanding your diagnosis and knowing your treatment options can help you feel more confident in your care.  

Outcomes4Me can support you by providing personalized, guideline-based treatment information and updates on the latest advances, helping you can take an active role in your care as cancer treatment continues to evolve.